Financhill
Back

KalVista Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56

KALV
KalVista Pharmaceuticals, Inc.

Last Price:
$15.80
Seasonality Move:
10.02%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KALV is experiencing slight selling pressure.

KalVista Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 15.66 Buy
20-day SMA: 15.62 Buy
50-day SMA: 13.4 Buy
200-day SMA: 12.99 Buy
8-day EMA: 15.72 Buy
20-day EMA: 15.34 Buy
50-day EMA: 14.22 Buy
200-day EMA: 12.94 Buy

KalVista Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 57.09 Buy
Chaikin Money Flow: -12629 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.82 - 16.5) Buy
Bollinger Bands (100): (11.47 - 14.97) Buy

KalVista Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for KalVista Pharmaceuticals, Inc. Stock

Is KalVista Pharmaceuticals, Inc. Stock a Buy?

KALV Technical Analysis vs Fundamental Analysis

Buy
56
KalVista Pharmaceuticals, Inc. (KALV) is a Buy

Is KalVista Pharmaceuticals, Inc. a Buy or a Sell?

KalVista Pharmaceuticals, Inc. Stock Info

Market Cap:
798.1M
Price in USD:
15.79
Share Volume:
307.3K

KalVista Pharmaceuticals, Inc. 52-Week Range

52-Week High:
17.30
52-Week Low:
7.30
Buy
56
KalVista Pharmaceuticals, Inc. (KALV) is a Buy

KalVista Pharmaceuticals, Inc. Share Price Forecast

Is KalVista Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of KalVista Pharmaceuticals, Inc.

Is KalVista Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.93 per share.

Technical Analysis of KalVista Pharmaceuticals, Inc.

Should I short KalVista Pharmaceuticals, Inc. stock?

* KalVista Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.